A Democratic member of Congress has emerged as a vocal defender of the status quo at the National Institutes of ...
Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 ...
To learn more, please visit www.reprievetrial.org.
As we reflect on five years since the tumultuous start of the COVID pandemic (even if we just wish to forget it ever happened ...
With uncertainties around federal funding for higher education, some schools are cutting back. Experts say that could hurt ...
Tecovirimat is Safe but Not Efficacious in People with Clade II Mpox Today's presentation, which was highlighted in a CROI press conference, found that tecovirimat did not reduce the time to clinical ...
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
Alpha-gal syndrome (AGS) is a severe tick-vectored food allergy caused by sensitivity to the galactose-alpha-1,3-galactose ...
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a ...
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to an integrase inhibitor-based antiretroviral regimen increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results